The in vitro cell invasion assay is used to measure the potential of cancer metastasis by quantifying the cellular potential for invasion and migration using cell culture inserts containing protein matrix. Cells are challenged to migrate through the protein matrix and a porous membrane, towards a chemoattractant, and then quantified by light microscopy.
The in vitro invasion assay uses a protein-rich matrix in a Boyden chamber to measure the ability of cultured cells to pass through the matrix and a porous membrane in a process analogous to the initial steps of cancer cell metastasis. The tested cells can be altered for the gene expression or treated with inhibitors to test for changes in the invasion potential. This experiment tests the aggressive phenotype of the mouse mammary tumor cells to discover and characterize the potential oncogenes that promote cell invasion. This technique, however, can be versatile and adapted to many different applications. The experiment itself can be done in one day and the results are acquired by light microscopy in less than a day. The results include counts of the number of invading cells for comparison and analysis. The in vitro invasion assay is a rapid, inexpensive, and clear-cut method for determining cell behavior in a culture that can be used as an initial assessment before more involved in vivo assays.
The in vitro invasion assay can be a useful tool when measuring a cell's ability to migrate through a protein-coated membrane, analogous to the first steps in metastasis. A key feature of malignant cancer cells is their ability to migrate through and invade nearby tissues. Cancer that has spread or metastasized poses more treatment challenges and has lower rates of long-term survival, while localized tumors are easier to treat and have higher rates of long-term survival. In order to metastasize, cancer cells must leave the primary tumor and migrate into the circulatory or lymphatic system, a process which requires passing through the extracellular matrix and basement membrane1. In the process called the epithelial mesenchymal transition (EMT), the tumor cells must break cell-cell contacts, migrate directionally, and invade nearby blood or lymph vessels. The initial steps of this metastasis cascade are of great interest since these steps are what can make cancer deadlier. The genetic and epigenetic factors involved in the early steps of metastasis are the focus of a great amount of research, but accurate and reliable experimental tools are needed to test these early steps both in vivo and in vitro.
Tools to measure changes in cell migration such as wound healing (scratch) assays or growth in 3D environments such as soft agar assays can partially address the need for experimental methods of measuring early steps of metastasis, but an assay to measure invasion is more challenging since the process occurs in the body within a complex tumor microenvironment. For the purposes of screening drugs or gene alterations to determine important factors in invasion and metastasis, a system that can be used in vitro with cultured cells and mimic the challenges faced by metastatic cells in vivo is the invasion assay2,3. Breast cancer is the most commonly diagnosed type of cancer in women and the second leading cause of cancer death in women, so understanding the genes responsible for breast cancer cell invasion and metastasis is critically important for public health. Moreover, mouse cells are a useful model system for studying breast cancer and its progression.
The in vitro invasion assay is based on the Boyden Chamber assembly where two chambers of growth media are separated by a porous membrane3. To mimic the tumor microenvironment, a protein-rich gel is also included to separate cells in one chamber from a chemoattractant in the other and act as a basement membrane barrier. In order to migrate towards the chemoattractant, cells must first pass through the protein-rich barrier then pass through the porous membrane – a process analogous to how metastatic cells migrate through stroma. The protein-rich gel can be altered based on the needs of the experiment, but usually consists of collagen, or basement membrane extract (e.g., Matrigel)4. It is a complex mixture of proteins, proteoglycans and growth factors, but mostly consists of laminins and collagen IV 4,5. Cells must then pass through a porous membrane typically made of polycarbonate, polyester, or polytetrafluoroethylene (PTFE). Membranes may be purchased commercially with or without a protein gel (typically collagens), or the gel may be purchased separately and added. The pore size can be adjusted based on the cell size. While pore sizes are available from 0.4 – 8.0 µm, only pores from 3.0 – 8.0 µm are large enough for cell migration. The invasion assay has been used to determine the effectiveness of inhibitors on the ability of cells to migrate and invade. While lacking the exact tumor microenvironment that is present in vivo, the in vitro invasion assay is beneficial at screening many conditions in a short time while minimizing the need for animal models. The goal of these experiments is to compare gene expression of suspected oncogenes and determine the effects on cancer cell behavior and disease aggressiveness using the in vitro invasion assay and other tests. Overall, the invasion assay provides consistent, quantitative, and rapid results for determining metastatic potential while also being a relatively inexpensive, straightforward, and adaptable method.
All experiments and methods were performed as authorized by Villanova University Institutional Animal Care and Use Committee (IACUC).
1. Gene Expression in Cultured Mouse Mammary Tumor Cells
2. In Vitro Invasion Assay
3. Imaging and Analysis
This method of in vitro invasion through a protein matrix was used to assess the aggressive phenotypes and oncogenic cell behaviors of mouse mammary tumor cells with altered expression of the zinc finger protein ZC3H88. In conjunction with other approaches that also examine cell migration and growth in 3D environments, it was found that higher levels of expression of Zc3h8 in tumor cell lines, or by promoter-mediated expression from a plasmid, resulted in rapid rates of cell proliferation, fast migration, growth in 3D environments, and increased invasion in the in vitro invasion assay8. Conversely, decreased expression by shRNA constructs resulted in less aggressive proliferation, migration, and invasion8. These results were confirmed in vivo where higher expression of Zc3h8 produced larger tumors that appeared rapidly, while decreased expression produced fewer tumors that were smaller and less frequent8.
To expand that this work, expression plasmids that can rescue shRNA-mediated knockdown of Zc3h8 expression were stably transfected in mouse mammary cells to evaluate if aggressive cell growth and behavior could be reestablished in these cells. All knockdown and rescue of expressions were verified by western blot or RT-qPCR8. An invasion assay was used with 5,000 cells per chamber in a 24-well dish and documented with photographs as shown in Figure 1 and Figure 2. Figure 3 shows the results of the invasion assay that demonstrate how cell invasion decreased upon shRNA knockdown of Zc3h8 expression, but that invasion is rescued when the expression is rescued. These data show that the invasion assay can provide a rapid method for testing cell lines in vitro before embarking on more expensive and lengthy approaches.
Figure 1: Invasion assay components. (A) Boyden chamber insert for a 24-well tissue culture dish. (B) A 24-well tissue culture dish used for fixation, staining, and washing after 22 h incubation with cells. Numbers 1, 2, and 3 are replicates of a single cell line. Please click here to view a larger version of this figure.
Figure 2: Invasion assay flowchart with the time scale. Please click here to view a larger version of this figure.
Figure 3: Sample invasion assay results of a mouse mammary tumor cells altered for expression of Zc3h8, which changes the oncogenic phenotype. (A, B) Cells isolated from mouse mammary tumors were stably transfected with shRNA targeting a control sequence of mRNA or targeting Zc3h8 mRNA. (C) The later cell line was then rescued by expressing recombinant Zc3h8 designed to be unaffected by shRNA. Cells are stained with crystal violet and captured at 10x magnification using a light microscope. Scale bar = 500 µm. (D) Quantification showing that reduced expression of Zc3h8 decreased the number of invading cells and the metastasis potential. Rescue of gene expression rescues higher rates of cell invasion. Values represent the total number of invading cells from a 24-well invasion assay insert. For each replicate in the experiment, the average number of invading cells was calculated. This was repeated for three experiments. Error bars indicate standard error of the mean. Please click here to view a larger version of this figure.
The in vitro invasion assay is an inexpensive, rapid, quantitative, and straightforward method for studying the factors promoting cancer cell invasion. Breast cancer is the most commonly diagnosed cancer among women. Of the three major subtypes of breast cancer, triple negative, (or ER-, PR-, HER2/neu-), is the most aggressive, most likely to metastasize, and most deadly9. Therefore, understanding the genes and expression that result in metastasis can help find new therapeutic targets and genetic markers for the disease. While many of the genes important for cancer cell invasion and metastasis have been identified and characterized, expression levels and activity of metastasis drivers versus metastasis suppressors may be a critical aspect of disease progression9,10.
Beyond gene expression, the in vitro invasion assay has also been used to study the role of microRNA and other regulators in either promoting or preventing cancer cell invasion11,12. The in vitro invasion setup method can be used for the study of inhibitors, multi-cell type tumor environments, CRISPR-edited cells, or short-term changes to cellular growth environments. The versatility and adaptability make this assay very advantageous.
The invasion assay may be used in a first step in the analysis of genes and factors that contribute to or prevent tumor progression. For instance, Yan et al. (2010) used the in vitro invasion assays to define the role of GATA-3 in suppressing the EMT by the highly aggressive breast cancer cell line MDA-MB 23113. They were then able to show that this suppression correlated with a decreased ability to form metastases in an in vivo assay13. Potential therapeutic strategies can be initially characterized by the ability of pathway inhibitors to limit invasion through Matrigel, also correlating with the effect of these inhibitors on tumor formation in animal models. The in vitro invasion assay can be used for more in-depth analysis of known and potential oncogenes and interacting partners. For example, molecular dissection of known functional motifs of an oncoprotein or rapid analysis of mutations can be done with the in vitro invasion assay as an initial screen or assessment of significance. This can provide valuable insight into critical domains as well as a functional understanding of cell phenotypes at the molecular level.
While the Boyden Chamber invasion assay has many advantages, there are limitations. For instance, the invasion assay only looks at intravasation, one of the initial steps of metastasis, but not the later steps when cancer cells colonize secondary locations. Therefore, only a partial view of metastasis potential can be concluded. The 22 h length of the assay, while flexible, cannot exclude some cell division that could skew subtle changes in measuring invasion of asynchronous cell populations. Inhibitors such as Mitomycin C can be used to prevent cell division in the case of rapidly diving cells. Lastly, the use of 5% FBS solution for chemotaxis will slowly diffuse over time and equilibrate between both the upper and lower chambers. The density of the protein gel slows this diffusion and presents the cells with the option of migrating laterally across the gel and membrane (haplotaxis) or through the protein matrix and through the pores towards the higher concentrations of FBS (chemotaxis). Alternative chemotaxis agents can be substituted or shorter time allowances for invasion can be used to measure only the cells that invaded prior to equilibration. It is the flexibility, not the rigidity, of the in vitro invasion assay that allows for customization that makes this assay so useful. Future adaptations of this assay include a large-scale screening of compounds, gene expression changes, and assessment of allele-specific drug effectiveness. Furthermore, a dual chamber system with circulating media could challenge cells to invade through a protein matrix, traverse a liquid environment, and reestablish on a second protein matrix at a secondary location. Lastly, a more challenging membrane can be used with the in vitro invasion assay system such as a monolayer of non-invasive cells that would be more difficult for cancer cells to cross.
The authors have nothing to disclose.
This work was supported by grant R15CA169978 from the National Institutes of Health. Additional funding came from Villanova University.
24-well plates | Corning | 353504 | |
Antibiotic-Antimycotic (100X) | ThermoFisher | 15240062 | |
BALB/c mice | |||
Cell Culture Incubator | |||
Cell Culture Treated Flasks | |||
Clinical cenrifuge | |||
Cotton swab | Puritan | 25-806 | |
Crystal Violet | Sigma Aldrich | C0775 | |
Distilled water | |||
DMEM | ThermoFisher | 10566-016 | high glucose, GlutaMAX |
Ethanol | |||
FBS | Sigma Aldrich | F2442-500ML | |
Forcepts | |||
Glass Slide | VWR | 16004-422 | |
HBSS | ThermoFisher | 14025076 | no calcium, no magnesium |
Hemocytometer | |||
Imersion oil | |||
Invasion Chambers (24-well) | Corning | 354480 | Cat. #354481 for 6-well |
Light Microscope | |||
Lipofectamine Transfection Reagent | |||
paraformaldehyde | Sigma Aldrich | P6148 | |
PBS | |||
Scalpel, disposable | #11 | ||
shRNA | |||
Sterile Transfer pipet | |||
Trypsin-EDTA | ThermoFisher | 25200056 |